School of Medicine
Showing 201-250 of 742 Results
-
Corey Keller, MD, PhD
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders. -
Jennifer Keller
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interestsinterpersonal violence and abuse prevention; empowerment of women; cognitive and affective information processing in depression; clinical, biological, and neuropsychological aspects of depression; South Asian mental health
-
Kevin Kelley
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAs a neuroscientist and psychiatrist, I am motivated by how little we understand about the pathophysiology of psychiatric disorders and hope that further knowledge will help to alleviate the ongoing distress of many of our patients. My research program leverages computational genomics, human brain cellular models, and molecular neuroscience techniques to understand the cellular and molecular mechanisms of human brain development and how dysfunction in these processes lead to psychiatric disorders.
-
Micah Kelly
Radiation and Cancer Biology Administrative Programs Lead, Radiation Oncology - Radiation Biology
Current Role at StanfordAdministrative Associate to Drs. Erinn Rankin, Richard Frock, and Ted Graves
-
Michael Kelly, MD, MSCI
Clinical Instructor, Orthopaedic Surgery
BioDr. Michael Kelly is a board-certified, fellowship-trained orthopaedic spine surgeon with Stanford Health Care. He is also a professor in the Department of Orthopaedic Surgery, Division of Spine Surgery at Stanford University School of Medicine.
Dr. Kelly is an expert in treating complex spinal deformities in children and adults, performing advanced surgeries and revision procedures to improve pain, movement, and posture. He specializes in managing scoliosis, spondylolisthesis, kyphosis, and other challenging back and neck problems. He has completed multiple fellowships in treating complex deformities, establishing his expertise in performing three-column osteotomy for spinal realignment. Dr. Kelly provides personalized care using the latest, evidence-based approaches to help his patients achieve a better quality of life.
With a master’s degree in clinical research, Dr. Kelly’s clinical care is driven by his extensive research on spinal deformities and innovations in orthopaedic medicine. His research focuses on improving safety, outcomes, and recovery for spinal surgeries, particularly for spinal deformities. Dr. Kelly’s work has helped define normal spinal alignment, improve surgical techniques, and better understand the long-term impacts of spinal deformity surgeries.
As a leader in orthopaedic surgery, Dr. Kelly has published hundreds of articles in peer-reviewed journals, including The New England Journal of Medicine, JAMA Surgery, The Lancet Neurology, and The Journal of Bone and Joint Surgery. He has shared his expertise at renowned international conferences, including annual meetings of the Scoliosis Research Society and the North American Spine Society (NASS). His presentations often discuss complex spinal deformities, spinal surgery techniques, and strategies to optimize patient care.
Dr. Kelly is a member of many professional organizations where he has also held leadership positions, including the Scoliosis Research Society, AO Spine, and the Cervical Spine Research Society. He is one of the few surgeons in the International Spine Study Group, dedicated to adult spinal deformity care, and the Harms Study Group, which focuses on pediatric spinal deformities. -
John L Kendall
Professor of Emergency Medicine (Adult Clinical/Academic)
BioJohn L. Kendall, MD, FACEP is Professor of Emergency Medicine at Stanford University School of Medicine, where he serves as Director of Academic Affairs, Director of Ultrasound, and Co-Director of Systemwide Point-of-Care Ultrasound (POCUS) for Stanford Health Care. A national leader in emergency and critical care ultrasound, he has published extensively on ultrasound education, quality assurance, and clinical applications, authoring more than 75 peer-reviewed publications and multiple textbooks. He is a Director of both the American Board of Emergency Medicine and the American Board of Medical Specialties, and has chaired numerous national committees shaping ultrasound certification and standards. His contributions to education, research, and leadership have been recognized with multiple national awards, including the Distinguished Service Award and Best Research in Medical Education Award from the Society for Academic Emergency Medicine and the Lifetime Service Award from the American College of Emergency Physicians.
-
Joan Kendig
Professor of Biology in the Department of Anesthesia, Emeritus
Current Research and Scholarly InterestsMy laboratory tries to find out how pharmacologic agents used in the practice of anesthesia (general anesthetic and analgesic agents) lead to therapeutically desireable endpoints including unconsciousness, immobility and absence of pain. The old idea that general anesthetics are uniformly non-specific "membrane stabilizers" is giving way to a new realization that these agents exert specific actions on particular ion channels and intracellular signalling systems.
-
Vanessa Kennedy
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Kennedy is a board-certified hematologist and medical oncologist who specializes in the treatment of myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myelofibrosis (MF). She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine.
Dr. Kennedy's research focuses on the use of clinical informatics and bioinformatics in understanding cancer biology and improving patient outcomes. She is also actively involved in interventional clinical trials. Her work has been supported by grant funding from the American Society of Clinical Oncology, the American Society of Hematology, and the Chan-Zuckerberg Foundation. -
Wayne Kepner
Postdoctoral Scholar, Psychiatry
BioWayne Kepner, PhD, MPH is a public health researcher whose scholarship focuses on health disparities and substance use among vulnerable populations. Dr. Kepner is currently a T-32 Post-doctoral Fellowship in Pain and Substance Use at Stanford University's School of Medicine, where he will continue his research under the mentorship of Dr. Keith Humphreys and Dr. Mark McGovern.
Dr. Kepner received his doctoral degree from the Joint Doctoral Program in Interdisciplinary Research on Substance Use at San Diego State University and the University of California, San Diego. His research focused on substance use disorders, health services utilization, and geospatial analysis of health data, with a particular emphasis on older adult populations. Dr. Kepner has extensive experience in both qualitative and quantitative research methods, having conducted interviews with older adults on cannabis use and analyzed large-scale electronic health records. He has co-authored several peer-reviewed publications on topics ranging from cannabis use trends to emergency department utilization for substance-related diagnoses. In addition to his academic work, Dr. Kepner is committed to community engagement, co-founding Aztecs For Recovery, a collegiate recovery program at SDSU. -
Samantha M Kerath
Director of Finance and Administration, Microbiology and Immunology
Current Role at StanfordDirector of Finance & Administration
Microbiology & Immunology and Baxter Lab -
John Kerner
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsI am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).
-
Andreas Kerschbaumer
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee. -
Andrew Kesselman
Clinical Associate Professor, Radiology
Current Research and Scholarly InterestsCurrently studying the role of interventional therapies in caval filtration, venous thromboembolism and primary and metastatic hepatic malignancies.
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Timothy Keyes
MD Student, expected graduation Spring 2026
Ph.D. Student in Cancer Biology, admitted Winter 2018
MSTP StudentBioTimothy is an MD/PhD student studying cancer biology and biomedical informatics at the Stanford University School of Medicine. He is a joint member of Kara Davis's laboratory in the Department of Pediatrics and Garry Nolan's Laboratory in the Department of Pathology.
As a biomedical data scientist, Timothy's research focuses on the application of machine learning to single-cell data analysis in the context of pediatric leukemia. Through the use of emerging, high-throughout single-cell technologies such as mass cytometry and sequence-based cytometry, Timothy's research is designed to build predictive models of patient outcomes - such as relapse or minimal residual disease (MRD) - at the point of diagnosis. To do so, he uses a variety of computational tools including generalized linear models, clustering, and deep learning. In addition, his work prioritizes constructing easy-to-use, highly-reproducible data analysis pipelines that can be shared as open-source tools for the scientific community.
Outside of science, Timothy has a longstanding interest in human rights and social justice work among members of the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) community. He currently serves as the resident data scientist for the Medical Student Pride Alliance (MSPA), a 501(c)(3) non-profit organization that advocates for diversity, equity, and inclusion for LGBTQ+ medicals students in medical schools across the United States. As a data scientist at MSPA, Timothy analyzes and visualizes data to guide MSPA's strategic decision-making as well as for academic publication. He also advises and mentors other student members of MSPA performing data analysis in Python and R.
In recognition of his accomplishments, Timothy has received several institutional and national award for both research and advocacy. These include a National Research Service Award (NRSA) from the National Cancer Institute, a Junior Leadership Award from the Building the Next Generation of Academic Physicians (BNGAP) LGBT Workforce, Stanford Medicine’s Integrated Strategic Plan Star Award, and a Point Foundation Scholarship. -
Harold Keyserling
Clinical Associate Professor (Affiliated), Rad/Veterans Affairs
Neuroradiologist, Radiology - Diagnostic RadiologyBioHarold Keyserling, MD is a diagnostic radiologist with subspecialty certification in neuroradiology. In addition to his clinical work, Dr. Keyserling is actively engaged in resident education and is a consulting radiologist for the Centers for Disease Control and Prevention (CDC), Division of Global Migration Health.
-
Steve Khachi, M.D.
Adjunct Lecturer, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Steve Khachi is a double-board-certified psychiatrist specializing in child, adolescent, and adult psychiatry. He is the Founder and Medical Director of the Mind Study Center in Pasadena, California—an integrated mental health clinic offering psychotherapy, medication management, neuropsychological evaluations, and transcranial magnetic stimulation (TMS). His clinic emphasizes interdisciplinary collaboration, clinical excellence, and innovation in care delivery.
Dr. Khachi serves as Adjunct Clinical Faculty at both Stanford University and the University of Southern California (USC), where he teaches and supervises child psychiatry fellows and residents. He is passionate about education and mentorship, and is committed to advancing the next generation of clinicians.
Dr. Khachi completed his Child and Adolescent Psychiatry Fellowship at Stanford University, where he served as Chief Fellow. He completed residency in General Psychiatry at UC San Diego, received his medical degree from the University of Wisconsin School of Medicine and Public Health, and earned his B.S. in Biochemistry–Molecular Biology from UC Santa Barbara. His additional training includes research fellowships at UCSF and the NIH/Howard Hughes Medical Institute. -
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science. Khaderi developed the discipline of Symbiotics following initial interest from CS students interested in his research at the Stanford Human Perception Lab. Symbiotics involves a deep understanding in the principles of human systems and applying these principles computationally, to design and develop the next generation of human-centric technologies, where machines perceive, understand and respond to optimize the human experience. Dr. Khaderi envisions the application of Symbiotic principles as the key to unlocking ambient intelligence.
Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including Apple, Google, Meta, Microsoft, Riot Games, Intel, Activision, Unity, Epic Games, NBA, Glaukos, the Global Esports Federation, the World Health Organization, the International Olympic Committee, the International Telecommunication Union, and the World Bank. -
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine.
In his clinical practice, he treats patients with all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. He also regularly attends on the inpatient oncology service at Stanford Hospital.
With each patient, he is devoted to providing exceptional, humanistic care and has been recognized throughout his career for his humanism. As a medical student, he was named to the national Gold Humanism Honor Society and he received the Reza Gandjei Humanism Award as a medical resident at UCSF.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He is the site principal investigator for multiple clinical trails investigating new therapies for genitourinary cancers.
Dr. Khaki is also active working clinically in inpatient oncology and is a Unit Based Medical Director for G1, an oncology hospital unit and is the Director of Inpatient Oncology. In this role, he oversees the inpatient oncology teams, works closely with the cancer center to develop new transitions of care pathways from inpatient to outpatient and has co-led an inpatient oncology research group to study quality improvement, care delivery and end-of-life care for patients with cancer.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. In addition, he is an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers.
